Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Ritter Pharmac. Com (RTTR)

3.37 0.05 (1.51%)

05-24 16:00

Open:

3.3

Pre. Close:

3.32

High:

3.43

Low:

3.211

Volume:

46,458

Market Cap:

17M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.433 - 3.446

3.446 - 3.462

Low:

3.176 - 3.189

3.189 - 3.205

Close:

3.344 - 3.366

3.366 - 3.392

Technical analysis  (as of: 2018-05-24 5:31:47 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 7.70     One year: 10.58

Support:

Support1: 2.59    Support2: 2.15

Resistance:

Resistance1: 6.59    Resistance2: 9.06

Pivot:

3.42

Moving Averages:

MA(5): 4.44     MA(20): 3.29

MA(100): 1.51     MA(250): 0.89

MACD:

MACD(12,26): 0.34     Signal(12,26,9): 0.36

%K %D:

%K(14,3): 10.51     %D(3): 20.20

RSI:

RSI(14): 50.75

52-Week:

High: 3.8  Low: 0.183  Change(%): 403.0

Average Vol(K):

3-Month: 41808  10-Days 13670

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
RTTR has closed above bottom band by 49.2%. Bollinger Bands are 438.4% wider than normal. The large width of the bands suggest high volatility as compared to RTTR's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

2018-05-17T12:40:15-04:00
Midday Gainers / Losers (05/17/2018)

2018-05-17T12:21:47-04:00
Healthcare - Top 5 Gainers / Losers as of 12:20 AM (05/17/2018)

2018-05-15T16:36:16-04:00
Ritter Pharmaceuticals misses by $0.01

2018-05-07T08:00:00-04:00
Your Daily Pharma Scoop: Alnylam Update, Malinckrodt's Adcom Failure, Anika's Drug Recall

2018-05-03T09:15:54-04:00
Premarket Gainers as of 9:05 am (05/03/2018)

2018-05-03T08:42:41-04:00
Ritter Pharma engages Medpace to conduct late-stage study of RP-G28 in lactose intolerance; shares up 10% premarket

2018-04-04T12:41:46-04:00
Midday Gainers / Losers (4/4/2018)

2018-03-19T09:05:13-04:00
Ritter Pharmaceuticals misses by $0.07

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

4.94

Shares Float (M)

4.80

% Held by Insiders

0.30

% Held by Institutions

0.40

Shares Short (K)

138

Shares Short Prior Month (K)

731

Stock Financials

EPS

-5.300

EPS Est. Current Year

-0.420

EPS Est. Next Year

-0.390

EPS Est. Next Quarter

-0.050

Forward EPS

-2.504

Book Value (p.s.)

0.970

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-73.0

Return on Equity (ttm)

-114.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.146

Qtrly Earnings Growth

Operating Cash Flow (M)

-7.40

Levered Free Cash Flow (M)

-4.48

atoplab.com

Valuation

P/E

-0.64

P/E Growth Ratio

0.02

P/BV

3.47

P/S

P/CF

-2.25

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.